Patent Abstracts of Japan, Kenichi, JP 08165240, Jun. 25, 1996, “Ketotifen-Containing Percutaneously Administering Preparation,”. |
European Search Report (EP 98 10 6046, Sep. 14, 1998). |
PCT International Search Report (PCT/EP99/02221, Mar. 31, 1999). |
Fujita et al., Clinical Efficacy and Optimal Concentration of Ketotifen Ophthalmic on Allergic Conjunctivitis and Vernal Conjunctivitis, J. Clinical Therapeutic and Medicines (Japan), 5(4):709-721, 1989. |
Kawasaki et al., Iyakuhin Kenkyu, vol. 19(5), “Eye Irritation Study on Ketotifen Fumarate-Containing Eye Drops in Rabbits (I) Eye Irritability on Single or Frequent Topical Instillation”, pp. 821-826, (1988) [English translation]. |
Kawasaki et al., Iyakuhin Kenkyu, vol. 19(5), “Eye Irritation Study on Ketotifen Fumarate-Containing Eye Drops in Rabbits (II) Eye Irritability on Successive Four-Week or Thirteen Week Instillations”, pp. 827-838, (1988) [English translation]. |
Mikuni et al., Rinsho Iyaku [Journal of Clinical Therapeutic and Medicines], vol. 4(12), “Evaluation of Ketotifen Ophthalmic Solution on Efficacy and Safety on Allergic Conjunctivitis and Vernal Conjunctivitis—Result on Multiclinic Open Trial—”, pp. 2371-2383, (1988) [English translation]. |
Mikuni et al., Ringan [Japanese Journal of Clinical Ophthalmology], vol. 36(6), “Quantitative Therapeutic Efficacy of Ketotifen Eye Drops for Allergic Conjunctivitis”, pp. 573-576, (1982) [English translation]. |
Mikuni et al., Tokai J Exp Clin Med., vol. 9, No. 1, “A Quantitative Tear Fluids Determination of Therapeutic Efficacy for Allergic Conjunctivitis”, pp. 35-41, (1984). |
Nakayasu et al., Safety of Ketotifen Ophthalmic Solution on Ocular External and Front Region, J. Clinical Therapeutic and Medicines (Japan), 4(12):2357-2369, 1989. |